The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating ...

Purdue is expected to raise and contribute $900m while dissolving and transforming into a new public benefit company. The non ...

Insight Health Data Research Hub and insitro have announced a partnership to develop an AI foundation model for ocular ...

Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipeline aimed at liver and central nervous system ...

Opko Health and Entera Bio have announced a partnership and licence agreement to progress the development of oral dual ...

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.

Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ataxia (FA) in individuals aged 16 years and ...

The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...

AstraZeneca has entered an exclusive licence agreement with Alteogen involving the latter’s ALT-B4 platform technology.

Experts at the 2025 Clinical Trial Supply New England conference will discuss strategies for optimising clinical supply ...

The two simultaneous Incyte trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.